Filed: 5/7/2025ACC: 0000950123-25-004223
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $60.21M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$60.21M
Total AUM (reported)
15.74M
Total Shares
Allocation by class
COMMON STOCK$43.24M71.8%
COMMON SHARES$16.97M28.2%
Portfolio Concentration
Top 3$49.60M82.4%
4–10$10.60M17.6%
Top 3 weight
82.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 15.74M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
15.74M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other7
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings7
Rows:
Monte Rosa Therapeutics, Inc.
OTRShares5.65M
TypeSH
Market value$26.23M
43.56%
Sole
0.00
Shared
5.65M
None
0.00
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$16.97M
28.18%
Sole
0.00
Shared
498.56K
None
0.00
Contineum Therapeutics, Inc.
OTRShares918.16K
TypeSH
Market value$6.41M
10.64%
Sole
0.00
Shared
918.16K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$3.19M
5.30%
Sole
0.00
Shared
2.01M
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$2.61M
4.33%
Sole
0.00
Shared
2.65M
None
0.00
Tempest Therapeutics, Inc.
OTRShares3.51M
TypeSH
Market value$2.59M
4.30%
Sole
0.00
Shared
3.51M
None
0.00
Adverum Biotechnologies, Inc.
OTRShares506.82K
TypeSH
Market value$2.21M
3.68%
Sole
0.00
Shared
506.82K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 5.65M | SH | $26.23M 43.56% | 0.00 | 5.65M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $16.97M 28.18% | 0.00 | 498.56K | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 918.16K | SH | $6.41M 10.64% | 0.00 | 918.16K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $3.19M 5.30% | 0.00 | 2.01M | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $2.61M 4.33% | 0.00 | 2.65M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 3.51M | SH | $2.59M 4.30% | 0.00 | 3.51M | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 506.82K | SH | $2.21M 3.68% | 0.00 | 506.82K | 0.00 |